Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
Event Time: | Monday May 6, 2019 3:30 pm to 5:30 pm |
Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology |
Director(s): | |
Description: | We're celebrating awards in a new way. Join us as we congratulate this year's winner of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases. The award presentation will be followed by a Q&A with a distinguished panel of past award recipients for an update on how this award has impact their careers. |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
3:30 PM - 3:40 PM | Welcome and Introduction | Bradley T. Hyman MD, PhD |
4:10 PM - 5:10 PM | Panel Member Presentations | David M. Holtzman MD, FAAN, Virginia Lee PhD, Reisa A. Sperling MD |
5:10 PM - 5:25 PM | Panel Discussion | Randall Bateman MD, David M. Holtzman MD, FAAN, Virginia Lee PhD, Reisa A. Sperling MD |
5:25 PM - 5:30 PM | Conclusion and Closing Remarks | Bradley T. Hyman MD, PhD |
Speaker | Disclosure |
---|---|
Randall Bateman, MD | co-founder of C2N Diagnostics. Dr. Bateman and Washington University in St. Louis have equity ownership interest in C2N Diagnostics. In addition, Dr. Bateman receives income from C2N Diagnostics for serving on the Scientific Advisory Board. Dr. Bateman may receive royalty income based on technology licensed by Washington University to C2N Diagnostics.. |
David M. Holtzman, MD, FAAN | Dr. Holtzman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with C2N Diagnostics, Genentech, Denali, Proclara. Dr. Holtzman has received personal compensation in an editorial capacity for Journal of Experimental Medicine. Dr. Holtzman has received royalty, license fees, or contractual rights payments from AbbVie, C2N Diagnostics, Denali, Eli Lilly. Dr. Holtzman has received research support from AbbVie, Eli Lilly, Denali, C2N Diagnostics. |
Bradley T. Hyman, MD, PhD | Dr. Hyman has received personal compensation for activities with Pfizer, Inc. as a scientific review board member. |
Virginia Lee, PhD | Dr. Lee has received personal compensation for activities with Janssen, Belgium and BMS as an invited speaker. |
Reisa A. Sperling, MD | Dr. Sperling has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Takeda, Roche. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C1 -
What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Daniel Kaufer MD, FAAN |
9:30 AM-11:30 AM |
C13 -
Clinicopathological Correlation Session in Dementia
David Irwin MD |
1:30 PM-3:30 PM |
C32 -
The Neurology of Social Behavior
Bradford Dickerson MD, FAAN |
4:15 PM-5:30 PM |
Hot Topics Plenary Session
Eric Klawiter MD, FAAN |
7:00 AM-9:00 AM |
---|
C37 -
Chronic Traumatic Encephalopathy: Update
Andrew Budson MD |
11:30 AM-6:30 PM |
P1 -
Poster Session 1
|
1:00 PM-3:00 PM |
C60 -
Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases
Michael Geschwind MD, PhD, FAAN |
3:30 PM-5:30 PM |
C76 -
Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions
Michael Geschwind MD, PhD, FAAN |
C67 -
Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
S9 -
Aging and Dementia: Clinical Trials and Novel Therapies
|
7:00 AM-9:00 AM |
---|
C78 -
Young Onset and Atypical Alzheimer's Dementia
Jonathan Graff-Radford MD |
C85 -
Severe TBI: From ICU to Rehabilitation
Susanne Muehlschlegel MD, MPH, FAAN |
8:00 AM-8:45 AM |
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease
Ergun Uc MD |
9:15 AM-12:00 PM |
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
11:30 AM-6:30 PM |
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
C88 -
Mild Cognitive Impairment: Implications for Clinicians
Ronald Petersen PhD, MD, FAAN |
S13 -
Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
|
3:30 PM-5:30 PM |
C106 -
Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment
David Knopman MD, FAAN |
5:00 PM-5:45 PM |
Defining, Evaluating, and Promoting Healthy Cognitive Aging
Kirk Daffner MD, FAAN |
7:00 AM-9:00 AM |
---|
C122 -
Neurocognitive Assessment for Neurologists
Mario Mendez MD, PhD, FAAN |
9:15 AM-11:30 AM |
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C132 -
Frontotemporal Dementias
Elizabeth Finger MD, FAAN |
3:30 PM-5:30 PM |
C151 -
Lewy Body Dementias
Karen Marder MD, MPH, FAAN |
7:00 AM-9:00 AM |
---|
C166 -
Neuroimaging Biomarkers Across the Dementia Spectrum
Liana Apostolova MD, FAAN |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-3:00 PM |
C176 -
Behavioral Neurology I: Network Anatomy of Behavior and Language
Maria Gorno Tempini MD, PhD |
S34 -
Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
|
3:30 PM-5:30 PM |
C193 -
Behavioral Neurology II: Memory and Attention
Maria Gorno Tempini MD, PhD |
5:00 PM-5:45 PM |
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit
David Perez MD, Aneeta Saxena MD, Gaston Baslet MD |
7:00 AM-9:00 AM |
---|
C206 -
Vascular Cognitive Impairment and Dementia: Current Status and Future
Larry Goldstein MD, FAAN, FAHA |
11:30 AM-6:30 PM |
P5 -
Poster Session 5
|
11:45 AM-12:30 PM |
How Your Social Life Might Be Helping (or Harming) Your Brain
Joel Salinas MD |
1:00 PM-3:00 PM |
C216 -
Higher Cortical Visual Disorders: Case-based Review
Sashank Prasad MD |
3:30 PM-5:30 PM |
IS3 -
Invited Science: Aging and Dementia
Karen Marder MD, MPH, FAAN, Heather Snyder PhD |
5:00 PM-5:45 PM |
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia
Ayesha Sherzai MD, Dean Sherzai MD, MAS, PhD |
7:00 PM-10:00 PM |
C242 -
Case Studies: Dementia
Gregory Day MD, MSc |
9:15 AM-11:30 AM |
---|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
11:45 AM-12:45 PM |
Friday Grand Finale: Neuroimaging
|
1:00 PM-3:00 PM |
C252 -
Update in Aging and Dementia
Gil Rabinovici MD |
3:30 PM-4:30 PM |
C255 -
Education Blitz: Normal Pressure Hydrocephalus
Neill Graff-Radford MD, FAAN |